Patient centered decision making in palliative cancer treatment: a world of paradoxes.

[1]  S H Heisterkamp,et al.  Palliative chemotherapy or watchful waiting? A vignettes study among oncologists. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  W. Chiu,et al.  Cancer Patients' Desires for Communication of Prognosis Information , 2002, Health communication.

[3]  L. Fallowfield,et al.  Participation of patients in decisions about treatment for cancer , 2001, BMJ : British Medical Journal.

[4]  Nicholas Christakis,et al.  Prognostic Disclosure to Patients with Cancer near the End of Life , 2001, Annals of Internal Medicine.

[5]  S. Jansen,et al.  Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile? , 2001, British Journal of Cancer.

[6]  D. Cella,et al.  Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Oza,et al.  Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  E. Eisenhauer,et al.  Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  K. McPherson,et al.  Cancer patients' information needs and information seeking behaviour: in depth interview study , 2000, BMJ : British Medical Journal.

[10]  J. Daurès,et al.  Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose. , 2000, American journal of clinical oncology.

[11]  Douglas K. Martin,et al.  Quality end-of-life care. , 2000, Journal of evaluation in clinical practice.

[12]  J. Kutner,et al.  Information needs in terminal illness. , 1999, Social science & medicine.

[13]  P. Singer,et al.  Quality end-of-life care: patients' perspectives. , 1999, JAMA.

[14]  R. Rubens,et al.  Do patients with advanced breast cancer benefit from chemotherapy? , 1998, British Journal of Cancer.

[15]  B. Rapkin,et al.  Communicating with patients about advanced cancer. , 1998, JAMA.

[16]  I. Tannock,et al.  Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. , 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[17]  I. Tannock.  Conventional cancer therapy: promise broken or promise delayed? , 1998, The Lancet.

[18]  A. D. Graeff,et al.  Gezamenlijk beslissen, hoezo ? Arts-patientcommunicatie over palliatieve chemotherapie , 1997 .

[19]  C. Naylor,et al.  Breast cancer patients' attitudes about rationing postlumpectomy radiation therapy: applicability of trade-off methods to policy-making. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  P. Butow,et al.  The dynamics of change: cancer patients' preferences for information, involvement and support. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  K C Carriere,et al.  Information needs and decisional preferences in women with breast cancer. , 1997, JAMA.

[22]  C. Charles,et al.  Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). , 1997, Social science & medicine.

[23]  R. Bremnes,et al.  Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy. , 1995, European journal of cancer.

[24]  D. Cella,et al.  Someone to live for: social well-being, parenthood status, and decision-making in oncology. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  H. Muss,et al.  Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  I. Tannock,et al.  Goals of palliative cancer therapy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. Sloan,et al.  Decision making during serious illness: what role do patients really want to play? , 1992, Journal of clinical epidemiology.

[28]  W. Gregory,et al.  Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. , 1990, BMJ.

[29]  G. Guyatt,et al.  Quality of life in stage II breast cancer: an instrument for clinical trials. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  A M Stiggelbout,et al.  Patient preference for cancer therapy: an overview of measurement approaches. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  J. Bensing,et al.  Bridging the gap. The separate worlds of evidence-based medicine and patient-centered medicine. , 2000, Patient education and counseling.

[32]  P. Oosterveld,et al.  De uitvoering van de informed consent vereiste in Nederlandse ziekenhuizen , 1998 .

[33]  C. Charles,et al.  Doing Nothing is No Choice: Lay Constructions of Treatment Decision‐making Among Women with Early‐stage Breast Cancer , 1998 .

[34]  R. Rubens.  Approaches to palliation and its evaluation. , 1993, Cancer treatment reviews.